175
Views
9
CrossRef citations to date
0
Altmetric
Original Article

CD34+CD90+ Cells and Late Hematopoietic Reconstitution after Autologous Peripheral Blood Stem Cell Transplantation

, &
Pages 661-668 | Received 15 Aug 2003, Published online: 03 Aug 2009

REFERENCES

  • Kessinger, A. and Armitage, J.0. (1991) "The evolving role of autologous peripheral blood stem cell transplantation following high-dose therapy for malignancies", Blood, 77, 211 — 213.
  • Shimazalci, C., Oku, N., Ashihara, E., Okawa, K., Goto, H., Inaba, T., etal. (1992) "Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicine followed by recombinant human granulocyte colony-stimulating factor", Bone Marrow Transplantation, 10, 341–346.
  • Uchida, N., Aguila, H.L., Fleming, W.H., Jerabek, L. and Weiss-man, I.L. (1994) "Rapid and sustained hematopoietic recovery in lethally irradiated mice transplanted with purified Thy-l.11°Lin - Sca-1 ± hematopoietic stem cells", Blood, 83, 3758— 3779.
  • Siena, S., Bregni, M., Brando, B., Belli, N., Ravagnani, F., Gandola, L., et al. (1991) "Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplan-tation in cancer patients", Blood, 77, 400–409.
  • Bensinger, W.L., Longin, K., Appelbaum, F., Rowley, S., Weaver, C., Lilleby, K., et al. (1994) "Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation", British Journal of Haematology, 87, 825–831.
  • Weaver, C.H., Hazelton, B., Birch, R., Palmer, P., Allen, C., Schwartzberg, L., et al. (1995) "An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy", Blood, 86, 3961–3969.
  • Henon, PH., Sovalat, H., Becker, M., Arkam, Y., Ojeda-Uribe, M., Raidot, J.P., et al. (1998) "Primordial role of CD34±CD38 cells in early and late trilineage haematopoietic engraftment after auto-logous blood stem cell transplantation", British Journal of Haematology, 103, 568 — 581.
  • Pecora, AL., Preti, R.A., Gleim, G.W., Jennis, A., Zahos, K., Cantwell, S., et al. (1998) "CD34 ±CD33 cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients", Journal of Clinical Oncology, 16, 2093— 2104.
  • Dercksen, MM., Rodenhius, S., Dirkson, M.K.A., Schaasberg, W.P., Baars, J.W., van der Wall, E., et al. (1995) "Subsets of CD34 ± cells and rapid hematopoietic recovery after peripheral blood stem cell transplantation", Journal of Clinical Oncology, 13, 1922— 1932.
  • Feng, R., Shimazaki, C., Inaba, T., Takahashi, R., Hirai, H., Kikuta, T., et al. (1998) "CD34 ±/CD41a± cells best predict platelet recovery after autologous peripheral blood stem cell transplanta-tion", Bone Marrow Transplantation, 21, 1217 — 1222.
  • Stewart, D.A., Guo, D., Luider, J., Auer, I., Klassen, J., Morris, D., et al. (1999) "Factors predicting engraftment of autologous blood stem cells: CD34 ± subsets inferior to the total CD34 ± cell dose", Bone Marrow Transplantation, 23, 1237 — 1243.
  • Menendez, P., Caballero, M.D., Prosper, F., Del Canizo, MC., Perez-Simon, JA., Mateos, MV., et al. (2002) "Transplantation of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization", Transfusion, 42, 1159 — 1172.
  • Haas, R., Witt, B., Mohle, R., Goldschmidt, H., Hohaus, S., Fruehaus, S., et al. (1995) "Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell support", Blood, 85, 3754— 3761.
  • Kiss, J.E., Rybka, W.B., Winkelstein, A., deMagalhhaes-Silverman, M., Lister, J., D'Andrea, P., et al. (1997) "Relationship of CD34± cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation", Bone Marrow Trans-plantation, 19, 303–310.
  • Amigo, ML., del Canizo, MC., Caballero, M.D., Vazquerz, L., Corral, M., Vidriales, B., et al. (1999) "Factors that influence long-term hematopoietic function following autologous stem cell transplantation", Bone Marrow Transplantation, 24, 289 — 293.
  • Perez-Simon, JA., Martin, A., Caballero, D., Corral, M., Nieto, Mi., Gonzalez, M., et al. (1999) "Clinical significance of CD34± cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation", Bone Marrow Transplantation, 24, 1279 — 1283.
  • Duggan, P.R., Guo, D., Luider, J., Auer, I., Klassen, J., Chaudhry, A., et al. (2000) "Predictive factors for long-term engraftment of autologous blood stem cells", Bone Marrow Transplantation, 26, 1299 — 1304. [9]
  • Sumikuma, T., Shimazaki, C., Inaba, T., Ochiai, N., Okano, A., Hatsuse, M., etal. (2002) "CD34±CD90± cells infused best predict late haematopoietic reconstitution following autologous peripheral blood stem cell transplantation", British Journal of Haematology, 117, 238 — 244.
  • To, L.B., Roberts, M.M., Haylock, D.N., Dyson, P.G., Branford, A.L., Thorp, D., et al. (1992) "Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplant", Bone Marrow Transplantation", 9, 277 — 284.
  • Bensinger, W.I., Singer, J., Appelbaum, F., Lilleby, K., Longin, K., Rowley, S., et al. (1993) "Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor", Blood, 81, 3158 — 3163.
  • Beyer, J., Schwella, J., Zingsem, J., Strohscheer, I., Oettle, H., Serke, S., et al. (1995) "Hematopoietic rescue after high dose chemother-apy using autologous peripheral blood progenitor cells or bone marrow. A randomized comparison", Journal of Clinical Oncology, 13, 1328 — 1335.
  • Schmitz, N., Linch, D.C., Dreger, P., Goldstone, A.H., Boogaerts, M.A., Ferrant, A., et al. (1996) "Randomized trial of filgrastim mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients", Lancet, 347, 353–357.
  • Benboubker, L., Cartron, G., Roingeard, F., Delain, M., Degenne, M., Linassier, C., et al. (2003) "Long-term marrow reconstitutive ability of autologous grafts in lymphoma patients using peripheral blood mobilized with granulocyte colony-stimulating factor or granulocyte-macrophage colony-stimulating factor compared to bone marrow", Experimental Hematology, 31, 89–97.
  • To, L., Haylock, D.N., Dowse, P.J., Simmons, P.J., Trimboli, S., Ashman, L.K., et al. (1994) "A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34 + cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34 + cells", Blood, 84, 2930–2939.
  • Tjonnfjord, G.E., Steen, R., Evensen, S., Thorsby, E. and Egeland, T. (1994) "Characterization of CD34 + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor", Blood, 84, 2795 — 2801.
  • Inaba, T., Shimazaki, C., Hirata, T., Ashihara, E., Okawa, K., Oku, N., et al. (1994) "Phenotypic differences of CD34-positive stem cells harvested from peripheral blood and bone marrow obtained before and after peripheral blood stem cell collection", Bone Marrow Transplantation, 13, 527–532.
  • Bolwell, B., Goormastics, M., Anderson, S., Koo, A., Wise, K., Overmoyer, B., et al. (1998) "Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation", Bone Marrow Transplantation, 22, 547 — 551.
  • Knudsen, L.M., Jensen, L., Jarlbaek, L., Hansen, PG., Hansen, S.W., Drivsholm, L., et al. (1999) "Subsets of CD34 hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation", Haematologica, 84, 517— 524.
  • Tricot, G., Jagannath, S., Vesole, D., Nelson, J., Tindle, S., Miller, L., et al. (1995) "Peripheral blood stem cell transplants for multiple myeloma: Identification of favourable variables for rapid engraft-ment in 225 patients", Blood, 85, 588 — 596.
  • Hirao, A., Kawano, Y., Takaue, Y., Suzue, T., Abe, T., Sato, J., et al. (1994) "Engraftment potential of peripheral and cord blood stem cells evaluated by a long-term culture system", Experimental Hematology, 22, 521–526.
  • Brendel, C. and Neubauer, A. (2000) "Characteristics and analysis of normal and leukemic stem cells: Current concepts and future direction", Leukemia, 14, 1711 — 1717.
  • Lansdorp, P.M., Sutherland, H.J. and Eaves, C.J. (1990) "Selective expression of CD45 isoforms on functional subpopulations of CD34 + hematopoietic cells from human bone marrow", Journal of Experimental Medicine, 172, 363–366.
  • Papayannopoulou, T., Brice, M., Broudy, V.C. and Zsebo, K.M. (1991) "Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: Functional properties and composite antigenic profile", Blood, 78, 1403–1412.
  • Drach, D., Zhao, S., Crach, J., Mahadevia, R., Gattringer, C., Huber, H., et al. (1992) "Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype", Blood, 80, 2729 — 2734.
  • Terstappen, L.W.M.M., Huang, S., Safford, M., Landsdorp, P.M. and Loken, M.R. (1991) "Sequential generation of hematopoietic colonies derived from single non lineage-committed CD34 ±CD38 — progenitor cells", Blood, 77, 1218 — 1227.
  • Bernstein, ID., Leary, A.G., Andrews, R.G. and Ogawa, M. (1991) "Blast colony-forming cells and precursors of colony-forming cells detectable in long-term marrow culture express the same phenotype (CD33 CD34)", Experimental Hematology, 19, 680–682.
  • Andrews, R.G., Singer, J.W. and Bernstein, I.D. (1989) "Precursors of colony-forming cells in human can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties", Journal of Experimental Medicine, 169, 1721–1731.
  • Pierelli, L., Teofili, L., Menichella, G., Rumi, C., Paoloni, A., Lovino, S., et al. (1994) "Further investigations on the expression of HLA-DR, CD33 and CD13 surface antigens in purified bone marrow and peripheral blood CD34 + haematopoietic progenitor cells", British Journal of Haematology, 84, 24–30.
  • Brandt, J., Baird, N., Lu, L., Srour, E. and Hoffman, R. (1988) "Characterization of a human hematopoietic progenitor cell capable of forming blast cell containing colonies in vitro", Journal of Clinical Investigation, 82, 1017 — 1027.
  • Siena, S., Bregni, M., Brando, B., Ravagnani, F., Bonadonna, G. and Gianni, AM. (1989) "Circulation of CD34 + hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor", Blood, 74, 1905 — 1914.
  • Baum, CM., Weissman, IL., Tsukamoto, AS., Buckle, A.M. and Peault, B. (1992) "Isolation of a candidate human hematopoietic stem cell population", Proceedings of National Academy of Science USA, 89, 2804–2808.
  • Miraglia, S., Godfrey, W., Yin, A.H., Atkins, K., Warnke, R., Holden, J.T., et al. (1997) "A novel five-transmembrane hemato-poietic stem cell antigen: Isolation, characterization, and molecular cloning", Blood, 90, 5013–5021.
  • Ziegler, B.L., Vertieri, M., Porada, G.A., De Maria, R., Muller, R., Masella, B., et al. (1999) "KDR receptor: A key marker defining hematopoietic stem cells", Science, 285, 1553— 1558.
  • Seiffert, N., Cant, C., Chen, Z., Rappold, I., Brugger, W., Kanz, L., et al. (1999) "Human signal-regulatory protein is expressed on normal, but not on subsets of leukemic myeloid cells and mediates cellular adhesion involving its counterreceptor CD47", Blood, 94, 3633— 3643.
  • Yin, A.H., Miraglia, S., Zanjani, E.D., Almeida-Porada, G., Ogawa, M., Leary, A., et al. (1997) "AC133, a novel marker for human hematopoietic stem and progenitor cells", Blood, 90, 5002–5012.
  • DeWynter, E.A., Buck, D., Hart, C., Heywood, R., Coutinho, L.H., Clayton, A., et al. (1998) "CD34 + AC133 + cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/ SCID-repopulating cells and dendritic cells progenitors", Stem Cells, 16, 387 — 396.
  • Peichev, M., Naiyer, A.J., Pereira, D., Zhu, Z., Lane, W.J., Williams, M., et al. (2000) "Expression of VEGFR-2 and AC133 by circulating human CD34 + cells identifies a population of functional endothelial precursors", Blood, 95, 952–958.
  • Williams, A.F. (1985) "Immunoglobulin-related domains for cell surface recognition", Nature, 314, 579 — 580.
  • Gunter, K.C., Malek, T.R. and Shevach, E.M. (1984) "T cell-activating properties of an anti-Thy-1 monoclonal antibody. Possible analogy to OKT3/Leu-4", Journal of Experimental Medicine, 159, 716–730.
  • He, H., Naquet, P., Caillol, D. and Pierres, M. (1991) "Thy-1 supports adhesion of mouse thymocytes to thymic epithelial cells through a Ca2± independent mechanism", Journal of Experimental Medicine, 173, 515 — 518.
  • Kroczek, R.A., Gunter, K.C., Seligmann, B. and Shevak, EM. (1986) "Induction of T-cell activation by monoclonal antiThy-1 antibodies", Journal of Immunology, 136, 4379–4384.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.